Post by
Breakthorough1 on Jul 27, 2023 1:49pm
January 10 2022
"The study is designed to be Stage 1 is, Does pembrolizumab plus (IMV’s) mavero equal better (results) than just pembro? And if it goes forward into Stage 2, the deal originally was that Merck would co-contribute to Stage 2 … so that as we push toward registration (of a commercial trial) Merck would be involved. So the first part of the study was ours to be funded; the second part is Merck’s to be funded. The reality was that it was more cost effective to close down the basket study … and the reason we are being a little coy with our press releases and we’re obviously still involved with Merck deeply and in conversations with Merck about how they want to fund the next step in bladder cancer and the next step in MSI-H (colon cancer, other tumors with high levels of micro-satellite instability. )"